Sign in

NCT07428590Not yet recruiting

Auricular Vagus Nerve Stimulation and Post-Stroke Dysphagia in Older Adults

Effect of Non-Invasive Auricular Vagus Nerve Stimulation on the Rehabilitation of Pharyngo-Laryngeal Dysphagia in Patients Over 70 Years Old After Stroke

Source: ClinicalTrials.gov · Last updated 24 Feb 2026

Brief summary (registry, in English)

This study investigates the effect of non-invasive transcutaneous auricular vagus nerve stimulation (tVNS-E) on swallowing rehabilitation in patients over 70 years old after stroke. Participants will be randomly assigned to standard speech therapy with either active tVNS-E or a sham device, over four sessions per week for three weeks. Swallowing function and quality of life will be assessed before and after the intervention to evaluate the potential benefit of tVNS-E.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
20 (estimated)
First submitted
19 Feb 2026
Start date
15 Mar 2026
Primary completion date
15 Feb 2028
Lead sponsor
Centre Hospitalier Universitaire de Nice
Diseases
Stroke
NCT number
NCT07428590

What you commit to

  • Study type: Interventional
  • Planned participants: 20
  • From 15 Mar 2026 to the primary completion date, 15 Feb 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Any associated medical condition preventing regular participation in rehabilitation activities at the time of inclusion.
  • Pre-existing dysphagia or dysphagia of non-stroke origin (e.g., myopathy, ENT cancer, laryngectomy).
  • Contraindications to vagus nerve stimulation (e.g., active epilepsy, active medical implants, severe cardiac pathology, severe uncontrolled psychiatric disorders).

Other

  • GUSS swallowing test score \<5/20 at baseline.
  • Legal protection under guardianship or curatorship, or inability to participate in a clinical trial under French Public Health Code Article L.1121-16.

Who the study is looking for

  • Age ≥ 70 years.
  • Acute stroke (0-1 month post-stroke).
  • Pharyngo-laryngeal dysphagia (Gugging Swallowing Screen, GUSS: 5/5 on preliminary test and \<4/5 on direct test, ignoring the drooling criterion which is not indicative of pharyngo-laryngeal dysphagia).
  • Ability to understand and follow experimental instructions.
  • Signed informed consent.
  • Participant covered by or beneficiary of a health insurance system.roke (0-1 month post-stroke)

Age in the registry: 70 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
CHU de Nice
Coordinator of this site? Confirm its status
NiceFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.